U.S. Study Shows Blood-Based Multicancer Early Detection Test Can ID Cancer Signals

FRIDAY, Sept. 25, 2026-- A blood-based multicancer early detection (MCED) test that predicts cancer signal origin (CSO) has a positive predictive value of 60.3 percent for participants aged 50 years or older without clinical suspicion of cancer...